Fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded sequence and application of fusion protein

2012 
The invention relates to a fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded nucleotide sequence and application of the fusion protein in treatment of malignant tumor.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    1
    References
    0
    Citations
    NaN
    KQI
    []